celecoxib has been researched along with fenretinide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Hong, WK; Lotan, D; Lotan, R; Schroeder, CP; Sun, SY; Yue, P | 1 |
Cherukuri, DP; Nelson, MA | 1 |
Hong, WK; Kadara, H; Lee, HY; Lotan, D; Lotan, R; Schroeder, CP; Woo, JK | 1 |
5 other study(ies) available for celecoxib and fenretinide
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspases; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inhibitors; Drug Synergism; Enzyme Activation; Fenretinide; Humans; Inhibitory Concentration 50; Lung Neoplasms; Pyrazoles; Sulfonamides | 2005 |
Could the combination of celecoxib and 4HPR be an effective lung cancer treatment?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclooxygenase 2 Inhibitors; Fenretinide; Humans; Lung Neoplasms; Pyrazoles; Sulfonamides | 2005 |
Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells.
Topics: Anticarcinogenic Agents; Apoptosis; Bronchi; Bronchial Diseases; Celecoxib; Cell Line, Tumor; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Drug Screening Assays, Antitumor; Drug Synergism; Epithelial Cells; Fenretinide; Humans; Lung Neoplasms; Mitochondria; Phosphorylation; Precancerous Conditions; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Pyrazoles; Recombinant Fusion Proteins; Sulfonamides | 2006 |